Published on May 26th, 2018 | by Daniel Sherman Fernandez0
Volvo XC40 Demand Overwhelming
Volvo Cars, the premium car maker, has received almost 80,000 orders for the new award-winning XC40 small SUV and is expanding production in Europe and China in order to meet demand. The XC40 was named European Car of the Year in March. It is Volvo’s first model in the fast-growing premium compact SUV segment, where is competes against the BMW X1, Jaguar E-Pace, Audi Q3 and Mercedes-Benz GLA.
The XC40 and its sibling compact models are crucial to Volvo’s plan to increase its global sales to 800,000 vehicles by 2020 from more than 571,000 last year.
Production will be expanded at its Ghent manufacturing plant and Volvo Cars will add XC40 production capacity at its Luqiao plant in China in the first half of next year, underlining the popularity of this year’s European Car of the Year.
In addition, the company has also announced today that it will capitalise on the popularity of its new smaller models with the introduction of new models on its Compact Modular Architecture (CMA), replacing the current V40.
“The XC40’s success has surpassed even our highest expectations,” said Håkan Samuelsson, president and CEO of Volvo Cars. “The small SUV segment is the fastest-growing segment in the industry now, and with these additional CMA-based models we expect to benefit further from that growth.”
The coming new models based on CMA will include fully electric vehicles and will be sold globally in all major regions. More product details will be disclosed at a later stage.
The XC40 was launched in late 2017 to global acclaim and was the first ever Volvo to win European Car of the Year in March of this year.
The new XC40 is the first model on Volvo Cars’ new CMA vehicle architecture. Co-developed with Geely Holding, CMA provides Volvo Cars with the necessary economies of scale for this segment.
In March, Volvo Cars announced it will produce cars for its new sister brand Lynk & Co at the Ghent plant. Like the XC40, the first Lynk & Co model is based on CMA.